Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Moxifloxacin punctal plug - Ocular Therapeutix

Next Previous
Search
Drug Profile

Moxifloxacin punctal plug - Ocular Therapeutix

Alternative Names: Moxifloxacin sustained-release - Ocular Therapeutix; OTX-MP

Latest Information Update: 23 Dec 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ocular Therapeutix
  • Class Antibacterials; Azabicyclo compounds; Cyclopropanes; Fluoroquinolones; Piperidines; Pyrrolidines; Small molecules
  • Mechanism of Action Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Conjunctivitis

Most Recent Events

  • 28 Jul 2018 No recent reports of development identified for phase-I development in Conjunctivitis in Singapore (Ophthalmic, Controlled release)
  • 20 May 2015 Pharmacokinetics and adverse events data from a phase I trial in Conjunctivitis (Bacterial conjunctivitis in post-cataract surgery patients) released by Ocular Therapeutix before May 2015 (Ocular Therapeutix From S-1; May 2015)
  • 20 May 2015 Ocular Therapeutix plans a phase II trial in Conjunctivitis (Bacterial conjunctivitis) in USA (Ocular Therapeutix From S-1; May 2015)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top